Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN
31/08/2026 03:41
BRIEF-BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN Aug 31 (Reuters) - BLS Pharmaceuticals Ltd BLS.AX:
FY REVENUE A$74.2 MILLION
FY NET PROFIT AFTER TAX OF A$15.4 MILLION
NO DIVIDENDS HAVE BEEN PAID OR ARE PROPOSED
Further company coverage: BLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results
Brief: BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%
Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN